NCT06773650 Proper Dietary Management, Follow-up, and Lactase Enzyme Supplementation for Lactose Intolerance
| NCT ID | NCT06773650 |
| Status | Recruiting |
| Phase | — |
| Sponsor | European Institute of Oncology |
| Condition | Lactose Intolerant |
| Study Type | OBSERVATIONAL |
| Enrollment | 385 participants |
| Start Date | 2025-01-08 |
| Primary Completion | 2026-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 385 participants in total. It began in 2025-01-08 with a primary completion date of 2026-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Lactose intolerance (LI) is considered the clinical syndrome caused by lactose malabsorption (LM). It is possible to identify four causes of lactase deficiency defining four different types of LM: primary (genetic), secondary (acquired), congenital (alactasia), and developmental (in premature infants, so reversible). The aim of this protocol is to investigate through an anonymous online survey the knowledge of the Italian population on clinical, pathophysiological, diagnostic and therapeutic issues of lactose intolerance. Data collected will be divulgated through a publication for both people with IL and nutritionists, enriched with tables and flow charts, to improve the knowledge on lactose intolerance and to support people suffering from this condition. The results of this survey will guide subjects suspected of suffering from lactose intolerance towards a correct diagnosis and a better management.
Eligibility Criteria
Inclusion Criteria: * Subjects must be adults (≥18 years of age) * Willingness to complete the online survey Exclusion Criteria: * Subjects \<18 years of age * Subjects not available to answer the online survey
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06773650 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Lactose Intolerant. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06773650 currently recruiting?
Yes, NCT06773650 is actively recruiting participants. Contact the research team at patrizia.gnagnarella@ieo.it for enrollment information.
Where is the NCT06773650 trial being conducted?
This trial is being conducted at Milan, Italy.
Who is sponsoring the NCT06773650 clinical trial?
NCT06773650 is sponsored by European Institute of Oncology. The trial plans to enroll 385 participants.